Nuvilex - 15 Year Stock Price History | PMCB

Historical daily share price chart and data for Nuvilex since 2011 adjusted for splits and dividends. The latest closing stock price for Nuvilex as of September 18, 2026 is 0.46.
  • The all-time high Nuvilex stock closing price was 765.04 on February 27, 2014.
  • The Nuvilex 52-week high stock price is 1.51, which is 228.3% above the current share price.
  • The Nuvilex 52-week low stock price is 0.33, which is 28.3% below the current share price.
  • The average Nuvilex stock price for the last 52 weeks is 0.76.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Nuvilex Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 0.6986 0.7380 0.9899 0.3823 0.4597 -36.51%
2025 1.1515 1.6401 1.8100 0.6300 0.7240 -53.89%
2024 1.9734 2.1850 2.5200 1.4700 1.5700 -27.31%
2023 2.6618 2.9300 3.1800 2.0100 2.1600 -26.28%
2022 2.4524 2.7700 3.0700 1.9100 2.9300 17.20%
2021 14.8461 11.2506 50.4025 2.2800 2.5000 -75.13%
2020 34.9106 61.2031 85.3543 6.3003 10.0505 -83.46%
2019 60.8913 58.7129 93.0047 48.0024 60.7530 9.46%
2018 86.0040 91.5046 147.4570 55.5028 55.5028 -33.69%
2017 112.9108 214.4960 214.4960 49.5025 83.7042 -62.53%
2016 91.1816 84.7542 234.7620 42.7521 223.3610 223.84%
2015 176.8013 288.0140 325.5160 68.9735 68.9735 -74.46%
2014 380.8679 171.7590 765.0380 171.7590 270.0130 76.47%
2013 157.6758 55.5028 308.8660 39.0020 153.0080 176.42%
2012 69.7818 70.5035 106.5050 36.0018 55.3528 -18.90%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.000B
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.766B 23.37
Takeda Pharmaceutical (TAK) Japan $60.592B 11.26
UCB SA (UCBJY) Belgium $45.206B 0.00
BeOne Medicines - (ONC) Switzerland $38.518B 61.77
Otsuka Holdings, - (OTSKY) Japan $37.978B 14.20
Sandoz Group AG (SDZNY) Switzerland $36.696B 0.00
Daiichi Sankyo, - (DSNKY) Japan $35.209B 21.98
Zoetis (ZTS) United States $29.504B 10.85
Astellas Pharma (ALPMY) Japan $27.471B 9.09
United Therapeutics (UTHR) United States $21.215B 17.70
Merck (MKKGY) Germany $19.225B 15.34
Shionogi (SGIOY) Japan $15.862B 9.32
IPSEN (IPSEY) France $15.003B 0.00
Neurocrine Biosciences (NBIX) United States $14.864B 20.20
Summit Therapeutics (SMMT) United States $14.240B 0.00
Orion OYJ (ORINY) Finland $13.312B 19.41
Madrigal Pharmaceuticals (MDGL) United States $12.280B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Corcept Therapeutics (CORT) United States $11.922B 262.60
Eisai (ESAIY) $9.158B 0.00
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Ionis Pharmaceuticals (IONS) United States $7.385B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.572B 32.88
Oruka Therapeutics (ORKA) United States $6.287B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.975B 21.76
Definium Therapeutics (DFTX) United States $5.215B 0.00
Grifols, S.A (GRFS) Spain $4.975B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.129B 0.00
Indivior Pharmaceuticals (INDV) United States $4.117B 9.56
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Enliven Therapeutics (ELVN) United States $3.623B 0.00
Amylyx Pharmaceuticals (AMLX) United States $3.611B 0.00
Dyne Therapeutics (DYN) United States $3.195B 0.00
Hypermarcas (HYPMY) Brazil $3.172B 9.01
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.688B 0.00
Nektar Therapeutics (NKTR) United States $2.291B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.249B 16.57
Guardian Pharmacy Services (GRDN) United States $2.240B 42.44
BioCryst Pharmaceuticals (BCRX) United States $2.218B 5.99
Ocular Therapeutix (OCUL) United States $2.194B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Xencor (XNCR) United States $1.838B 0.00
KARDIGAN INC (KARD) United States $1.556B 0.00
Xeris Biopharma Holdings (XERS) United States $1.495B 117.14
Harrow (HROW) United States $1.240B 0.00
Cronos Group (CRON) Canada $1.235B 30.45
Apnimed (APMD) $1.207B 0.00
Aktis Oncology (AKTS) United States $1.176B 0.00
Seaport Therapeutics (SPTX) United States $1.145B 0.00
Savara (SVRA) United States $1.103B 0.00
Bioventus (BVS) United States $1.086B 16.99
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.974B 0.00
Avalo Therapeutics (AVTX) United States $0.889B 0.00
Theravance Biopharma (TBPH) United States $0.884B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.863B 11.90
Ardelyx (ARDX) United States $0.852B 0.00
4D Molecular Therapeutics (FDMT) United States $0.841B 0.00
Achieve Life Sciences (ACHV) Canada $0.821B 0.00
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.769B 0.00
Collegium Pharmaceutical (COLL) United States $0.741B 3.26
Silence Therapeutics (SLN) United Kingdom $0.735B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.720B 5.59
Zevra Therapeutics (ZVRA) United States $0.689B 7.35
OmniAb (OABI) United States $0.647B 0.00
Altimmune (ALT) United States $0.632B 0.00
Aquestive Therapeutics (AQST) United States $0.579B 0.00
ProKidney (PROK) United States $0.577B 0.00
Evotec AG (EVO) Germany $0.569B 0.00
Indaptus Therapeutics (INDP) United States $0.473B 0.00
Relmada Therapeutics (RLMD) United States $0.439B 0.00
ARS Pharmaceuticals (SPRY) United States $0.409B 0.00
Larimar Therapeutics (LRMR) United States $0.394B 0.00
Prelude Therapeutics (PRLD) United States $0.389B 0.00
Lexeo Therapeutics (LXEO) United States $0.345B 0.00
Avita Medical (RCEL) United States $0.339B 0.00
Century Therapeutics (IPSC) United States $0.337B 0.00
Inhibikase Therapeutics (IKT) United States $0.321B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
Lyell Immunopharma (LYEL) United States $0.270B 0.00
Elite Pharmaceuticals (ELTP) United States $0.267B 12.38
USANA Health Sciences (USNA) United States $0.261B 14.28
Galectin Therapeutics (GALT) United States $0.256B 0.00
Akebia Therapeutics (AKBA) United States $0.254B 0.00
Nature's Sunshine Products (NATR) United States $0.229B 11.13
Siga Technologies (SIGA) United States $0.226B 0.00
AleAnna (ANNA) United States $0.218B 17.21
Cardiol Therapeutics (CRDL) Canada $0.218B 0.00
Profound Medical (PROF) Canada $0.214B 0.00
Protara Therapeutics (TARA) United States $0.210B 0.00
Journey Medical (DERM) United States $0.206B 0.00
Surrozen (SRZN) United States $0.192B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.186B 0.00
Organogenesis (ORGO) United States $0.183B 0.00
Minerva Neurosciences (NERV) United States $0.175B 0.00
MediWound (MDWD) Israel $0.172B 0.00
Atrium Therapeutics (RNA) United States $0.153B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
NRx Pharmaceuticals (NRXP) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.140B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.134B 0.00
VAXART, INC (VXRT) United States $0.118B 3.04
Assertio Holdings (ASRT) United States $0.116B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
ElectroCore (ECOR) United States $0.105B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
PolyPid (PYPD) Israel $0.099B 0.00
Nutriband (NTRB) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
HST Global (HSTC) United States $0.092B 0.00
Telomir Pharmaceuticals (TELO) United States $0.085B 0.00
Aldeyra Therapeutics (ALDX) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.080B 0.00
Acrivon Therapeutics (ACRV) United States $0.079B 0.00
Gain Therapeutics (GANX) United States $0.077B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Champions Oncology (CSBR) United States $0.074B 0.00
Nuo Therapeutics (AURX) $0.063B 0.00
Talphera (TLPH) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.059B 0.00
Heron Therapeutics (HRTX) United States $0.059B 0.00
Veraxa Biotech AG (VRXA) United States $0.046B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.044B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Context Therapeutics (CNTX) United States $0.034B 0.00
Cosmos Health (COSM) United States $0.032B 0.00
Optimi Health (OPTH) Canada $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.024B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Tempest Therapeutics (TPST) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Enlivex (ENLV) Israel $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00